Chemoinformaics analysis of (3E,5Z)-octa-3,5-dien-2-one
Molecular Weight | 124.183 | nRot | 3 |
Heavy Atom Molecular Weight | 112.087 | nRig | 1 |
Exact Molecular Weight | 124.089 | nRing | 0 |
Solubility: LogS | -4.641 | nHRing | 0 |
Solubility: LogP | 4.947 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 22.1635 |
nHD | 0 | BPOL | 12.9065 |
QED | 0.353 |
Synth | 1.889 |
Natural Product Likeliness | 0.99 |
NR-PPAR-gamma | 0.495 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.028 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.684 |
MDCK | 0.0000162 |
BBB | 0.983 |
PPB | 0.815989 |
VDSS | 2.683 |
FU | 0.061207 |
CYP1A2-inh | 0.636 |
CYP1A2-sub | 0.241 |
CYP2c19-inh | 0.464 |
CYP2c19-sub | 0.086 |
CYP2c9-inh | 0.257 |
CYP2c9-sub | 0.909 |
CYP2d6-inh | 0.138 |
CYP2d6-sub | 0.155 |
CYP3a4-inh | 0.193 |
CYP3a4-sub | 0.066 |
CL | 3.906 |
T12 | 0.256 |
hERG | 0.284 |
Ames | 0.038 |
ROA | 0.025 |
SkinSen | 0.971 |
Carcinogencity | 0.208 |
EI | 0.966 |
Respiratory | 0.965 |
NR-Aromatase | 0.082 |
Antiviral | No |
Prediction | 0.956486 |